New patent for Abbvie drug NAMZARIC

Annual Drug Patent Expirations for NAMZARIC Namzaric is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twelve patents protecting…

The post New patent for Abbvie drug NAMZARIC appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog